Systematic literature review of clinical outcomes in adults with metastatic or advanced synovial sarcoma.

Background: Materials & methods: Results: Conclusion: Synovial sarcoma (SS) is a rare, aggressive soft tissue sarcoma with a poor prognosis after metastasis. The objective of this study was to conduct a systematic review of the clinical evidence for therapeutic options for adults with metastatic or advanced SS.Relevant databases were searched with predefined keywords.Thirty-nine publications reported clinical data for systemic treatment and other interventions. Data on survival outcomes varied but were generally poor (progression-free survival: 1.0-7.7 months; overall survival: 6.7-29.2 months) for adults with metastatic and advanced SS. A high frequency of neutropenia with systemic treatment and low quality of life post-progression were reported.Reported evidence suggests poor outcomes in adults with metastatic and advanced SS and the need for the development of new treatment modalities.